Greenline Partners’s Organon & Co OGN Stock Holding History

Greenline Partners’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-48	Closed	-$715	–	440
2025 Q1	$715	Hold	48	–	–	﹤0.01%	439
2024 Q4	$716	Buy	+48	New	+$782	﹤0.01%	240

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Greenline Partners's OGN Position: Q2 2025 in Review

Greenline Partners sold out of Organon & Co (OGN) in Q2 2025, closing a stake of 48 shares — an estimated $715 sold.

Greenline Partners first reported a position in OGN in Q4 2024 and held it in 2 quarters. The position peaked at $716 in Q4 2024. 696 funds tracked by Wall St. Rank hold OGN as of Q2 2025.

Greenline Partners reported no remaining Organon & Co position as of Q2 2025 after selling out during the quarter.
Greenline Partners sold 48 Organon & Co shares in Q2 2025, an estimated $715.
Greenline Partners first reported a position in Organon & Co in Q4 2024 and held it in 2 quarters.
Greenline Partners's Organon & Co position peaked at $716 in Q4 2024.
696 funds tracked by Wall St. Rank held Organon & Co as of Q2 2025.

Based on Greenline Partners's 13F filing for Q2 2025, filed 14 Aug 2025.